CASE REPORT ON TWO CONSECUTIVE PATIENTS WITH NEUROINVASIVE WEST NILE VIRUS INFECTION IN AN INTENSIVE CARE UNIT
DOI:
https://doi.org/10.58395/x3z0jw80Keywords:
West Nile Virus, fever, neuroinvasive disease, encephalitisAbstract
We present the clinical course, and treatment of two consecutive cases of neuroinvasive West Nile virus (WNV) infection in the Clinic of Intensive Care, an Intensive Care Unit (ICU) at the Military Medical Academy - Sofia. Clinical and epidemiological data, microbiological, laboratory, molecular methods, and imaging techniques were used. Both patients resided in Sofia, Bulgaria, and had not travelled in recent months. The first case was a 60-year-old man who have had mental status changes, fever, and progression of existing Parkinson's disease. Antibodies to WNV were present in cerebrospinal fluid (CSF). His condition worsened with the development of sepsis and respiratory failure and he ended up lethally. The second case was a 72-year-old man who had fever and lower dyspeptic syndrome for one week, mental status changes, with adynamia to inability to walk independently, and head, hand and tongue tremors. CSF analysis showed mild pleocytosis with proteinorachy. Antibodies to WNV were present in serum, and PCR for WNV in urine was positive. The patient was admitted to ICU due to worsened mental and neurological status, coma and development of acute respiratory failure, necessitating intubation and assisted pulmonary ventilation. The patient ended lethally 13 days later. Neuroinvasive WNV infection can cause substantial morbidity, particularly among older adults, and high mortality, in the presence of comorbidities. Physicians should include West Nile virus infection in the differential diagnosis of aseptic meningitis and encephalitis, should perform appropriate laboratory tests, and report immediately the cases to the public health authorities.
Downloads
References
1. Factsheet about West Nile virus infection. ECDC. Online: https://www.ecdc.europa.eu/en/west-nile-fever/facts. Last access: 01.11.2024
2. West Nile virus infection - Annual Epidemiological Report for 2019. Stokholm: ECDC; 2021. Online: https://www.ecdc.europa.eu/sites/default/files/documents/AER-WNV-infection-2019.pdf. Last access: 01.11.2024
3. Argirova P, Kalchev Y, Vasilev P, Christova I, Stoycheva M, Murdjeva M. West Nile virus meningoencephalitis and cytokines analysis: review and case report. Biotechnol Biotechnol Equip. 2024; 38(1):2358991. https://doi.org/10.1080/13102818.2024.2358991
4. Baymakova M, Trifonova I, Panayotova E, Dakova S, Pacenti M, Barzon L, Lavezzo E, Ramshev K, Plochev K, Christova I. West Nile virus neuroinvasive disease: The first confirmed case in Bulgaria. Int J Infect Dis. 2016; 53:150. https://doi.org/10.1016/j.ijid.2016.11.368
5. Kotsev S, Christova I, Pishmisheva-Peleva M. West Nile Fever - Clinical and Epidemiological Characteristics. Review of the Literature and Contribution with Three Clinical Cases. Fol Med (Plovdiv). 2020; 62(4):843-850. https://doi.org/10.3897/folmed.62.e51225
6. Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med. 2010; 30(1):47-65. https://doi.org/10.1016/j.cll.2009.10.006
7. Gyure KA. West Nile virus infections. J Neuropathol Exp Neurol. 2009; 68(10):1053-60. https://doi.org/10.1097/NEN.0b013e3181b88114
8. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis. 2005; 11(8):1167-73. https://doi.org/10.3201/eid1108.050289a
9. Sambri V, Capobianchi M, Charrel R, Fyodorova M, Gaibani P, Gould E, Niedrig M, Papa A, Pierro A, Rossini G, Varani S, Vocale C, Landini MP. West Nile virus in Europe: Emergence, epidemiology, diagnosis, treatment, and prevention. Clin. Microbiol. Infect. 2013; 19:699–704. https://doi.org/10.1111/1469-0691.12211
10. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013; 310(3):308-15. https://doi.org/10.1001/jama.2013.8042
11. Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, Pape J, Reeves WC, Campbell GL. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. Journal of neuropsychology. 2008; 2(2):477-99. https://doi.org/10.1348/174866407x218312
12. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003; 290(4):511-5. https://doi.org/10.1001/jama.290.4.511
13. Montgomery RR. Age-related alterations in immune responses to West Nile virus infection. Clin Exp Immunol. 2017; 187(1):26-34. https://doi.org/10.1111/cei.12863
14. Danis K, Papa A, Theocharopoulos G, Dougas G, Athanasiou M, Detsis M, Baka A, Lytras T, Mellou K, Bonovas S, Panagiotopoulos T. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis. 2011; 17(10):1868-72. https://doi.org/10.3201/eid1710.110525
15. Pervanidou D, Detsis M, Danis K, Mellou K, Papanikolaou E, Terzaki I, Baka A, Veneti L, Vakali A, Dougas G, Politis C, Stamoulis K, Tsiodras S, Georgakopoulou T, Papa A, Tsakris A, Kremastinou J, Hadjichristodoulou C. West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmission. Euro Surveill. 2014; 19(13):20758. https://doi.org/10.2807/1560-7917.es2014.19.13.20758
16. DeBiasi, R.L. West Nile Virus Neuroinvasive Disease. Curr Infect Dis Rep. 2011; 13, 350–359. https://doi.org/10.1007/s11908-011-0193-9
17. Gorchakov R, Gulas-Wroblewski BE, Ronca SE, Ruff JC, Nolan MS, Berry R, Alvarado RE, Gunter SM, Murray KO. Optimizing PCR Detection of West Nile Virus from Body Fluid Specimens to Delineate Natural History in an Infected Human Cohort. Int J Mol Sci. 2019; 20(8):1934. https://doi.org/10.3390/ijms20081934
18. Lanciotti RS, Kerst AJ. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol. 2001; 39(12):4506-13. https://doi.org/10.1128/JCM.39.12.4506-4513.2001
19. Tyler KL, Pape J, Goody RJ, Corkill M, Kleinschmidt-DeMasters BK. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology. 2006; 66(3):361-5. https://doi.org/10.1212/01.wnl.0000195890.70898.1f
20. Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci. 2004; 220(1-2):37-40. https://doi.org/10.1016/j.jns.2004.01.013
21. Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005; 26(2):289-297.
22. Petropoulou KA, Gordon SM, Prayson RA, Ruggierri PM. West Nile virus meningoencephalitis: MR imaging findings. AJNR Am J Neuroradiol. 2005; 26(8):1986-95.
23. Loginova SIa, Borisevich SV, Pashchenko IuA, Bondarev VP. In Russian [Ribavirin prophylaxis and therapy of experimental West Nile fever]. Antibiot Khimioter. 2009; 54(11-12):17-20.
24. Odelola H. A. Antiviral activity of Virazole on replication of viruses isolated in Nigeria. Current Chemotherapy / Siegenthaler W., Lathy R. eds.Washington: American Society of Microbiology. 1978; 1: 3343—3345.
25. Jordan I, Briese T, Fischer N, Lau JY, Lipkin WI. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis. 2000; 182(4):1214-7. https://doi.org/10.1086/315847
26. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis. 2002; 8(1):107-108. https://doi.org/10.3201/eid0801.010252
27. Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager- Zisman B. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis. 2003; 188(1):5-12. https://doi.org/10.1086/376870
28. Konkolova E, Dejmek M, Hřebabecký H, Šála M, Böserle J, Nencka R, Boura E. Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses. Antiviral Res. 2020; 182:104899. https://doi.org/10.1016/j.antiviral.2020.104899
29. Radoshitzky SR, Iversen P, Lu X, Zou J, Kaptein SJF, Stuthman KS, Van Tongeren SA, Steffens J, Gong R, Truong H, Sapre AA, Yang H, Xie X, Chia JJ, Song ZJ, Leventhal SM, Chan J, Shornikov A, Zhang X, Cowfer D, Yu H, Warren T, Cihlar T, Porter DP, Neyts J, Shi PY, Wells J, Bilello JP, Feng JY. Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro. Sci Rep. 2023; 13(1):3131. https://doi.org/10.1038/s41598-023-29517-9
30. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, Hartman BJ, Kaplan SL, Scheld WM, Whitley RJ; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008; 47(3):303-27. https://doi.org/10.1086/589747
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Silviya Stoyanova, Raynichka Mihaylova-Garnizova, Emilia Naseva, Severina Dakova, Iva Christova, Konstantin Ramshev (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.